Skip to main navigation Skip to search Skip to main content

Prognostic factors of survival with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as second-line therapy for patients with metastatic colorectal cancer

  • Sungkyunkwan University
  • Inha University

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic factors of survival with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as second-line therapy for patients with metastatic colorectal cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science